Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysisAdela Escudero, Guillermo Villacampa, Andri Papakonstantinou et al.|Cancer Treatment Reviews|2025Cited by 3
Abstract P2-05-18: Molecular effects of short pre-operative endocrine therapy in hormone receptor-positive and HER2-negative early breast cancerRaquel Gómez Bravo, Fara Brasó‐Maristany, Bárbara Adamo et al.|Clinical Cancer Research|2025Cited by 0